CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the skin microbiome's role in adverse reactions to the cancer drug capecitabine. By analyzing microbial interactions and their effects on drug metabolism, the research aims to enhance personalized medicine approaches in cancer treatment.
The microbiome plays relevant functions on human health and disease, including roles in the efficacy and security of drug treatments.
Capecitabine is a pro-drug of 5-fluorouracil, which is an active metabolite that targets tumor cells.
This treatment is used for diverse cancers, including colon tumors, and is commonly associated with diverse adverse reactions such as the hand-foot syndrome (HFS), a skin deterioration for which there has not been discovered its causal mechanism.
Preliminary data…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Salamanca
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
